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Abstract
Background: Occupational exposures to ultrafine particles in the plume generated during laser hair removal
procedures, the most commonly performed light based cosmetic procedure, have not been thoroughly characterized.
Acute and chronic exposures to ambient ultrafine particles have been associated with a number of negative respiratory
and cardiovascular health effects. Thus, the aim of this study was to measure airborne concentrations of particles in a
diameter size range of 10 nm to 1 μm in procedure rooms during laser hair removal procedures.
Methods: TSI Model 3007 Condensation Particle Counters were used to quantify the particle count concentrations in
the waiting and procedure rooms of a dermatology office. Particle concentrations were sampled before, during, and
after laser hair removal procedures, and characteristics of each procedure were noted by the performing dermatologist.
Results: Twelve procedures were sampled over 4 days. Mean ultrafine particle concentrations in the waiting and
procedure rooms were 14,957.4 particles/cm3 and 22,916.8 particles/cm3 (p < 0.0001), respectively. Compared to
background ultrafine particle concentrations before the procedure, the mean concentration in the procedure room
was 2.89 times greater during the procedure (p = 0.009) and 2.09 times greater after the procedure (p = 0.007). Duration
of procedure (p = 0.006), body part (p = 0.013), and the use of pre-laser lotion/type of laser (p = 0.039), were the most
important predictors of ultrafine particle concentrations. Use of a smoke evacuator (a recommended form of local
exhaust ventilation) positioned at 30.5 cm from the source, as opposed to the recommended 1–2 in., lowered particle
concentrations, but was not a statistically significant predictor (p = 0.49).
Conclusions: Laser hair removal procedures can generate high exposures to ultrafine particles for dermatologists and
other individuals performing laser hair removal, with exposure varying based on multiple determinants.
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Background
Laser hair removal (LHR) procedures are one of the top five
most popular non-invasive procedures performed in the
United States, with over 1.1 million treatments conducted
in 2014 [1]. Invented in 1998, LHR is based on the theory
of extended selective photothermolysis in which the laser
device delivers light energy at a specific wavelength and
pulse duration targeting melanin in hair follicles [2]. During
the procedure, a malodorous and often visible plume is
generated.
To date, little is known regarding exposures to LHR
plume, although the surgical plume generated from electro-
cautery devices is a known occupational hazard for clini-
cians [3–11]. A recent study by Chuang et al. documented
high levels of ultrafine particles (UFP), particles less than
1 μm in aerodynamic diameter, during a LHR procedure
[12]. As part of the same study, a total of 63 chemical com-
pounds (including 13 known or suspected carcinogens)
were identified in plumes generated during experimental
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LHR simulations, and 7 chemicals (acetonitrile, acrylonitrile,
toluene, ethylbenzene, styrene, propene, and carbon mon-
oxide) were detected in air samples taken during the single
LHR procedure [12]. Using smoke evacuators, a form of
local exhaust ventilation, at a distance of 1–2 in. from the
laser has been recommended to control exposure to LHR
plumes. However, even with the use of a smoke evacuator
in close proximity (5.0 cm from procedure site), Chuang et
al. observed that the concentration of UFP at face level of
the laser practitioner during a LHR treatment was 8 times
higher than the ambient concentration in the procedure
room prior to the treatment, indicating that the smoke
evacuator does not fully eliminate the potential for UFP
exposures [12].
Chronic exposure to ambient particulate matter
(PM) has been linked to detrimental health effects,
including lung cancer and other cardiopulmonary dis-
eases [1, 13–16]. The literature on the health effects of
UFP is growing rapidly [17]. Acute exposure to ambient
UFP has been associated with decreased lung function,
decreased heart rate variability, increased inflammation
and coagulation in the lungs and peripheral blood, and
risk of myocardial infarctions [18–24]. Chronic ambient
exposure to UFP has been associated with increased risks
of overall and cardiovascular mortality and increased
systemic inflammation and oxidative stress [17, 25, 26].
Although there is growing literature on the adverse
health effects of ambient exposures to UFP, little is known
regarding occupational exposures to UFP during LHR.
The goal of this study was to assess the occupational
exposure to UFP during LHR in a clinical setting over a
series of typical workdays, compare levels of exposure
before, during, and after LHR procedures, and identify
factors associated with increased UFP exposures.
Methods
Study location
The study was performed at the Massachusetts General
Hospital Dermatology Laser & Cosmetic Center in
Boston, MA. The Center was located in a suite of an of-
fice building and the ventilation in the procedure rooms
was typical of general office building ventilation systems.
Sampling occurred over four typical work days (based
on number of and types of procedures). Data collection
occurred in the waiting room and two procedure rooms
of the clinic for the duration of each work day. Sampling
occurred during all scheduled procedures on the selected
days. Either an Alexandrite laser (755 nm, pulse duration
3 ms, cryogen-spray cooling, Candela Gentelase. Wayland,
MA) or Diode laser (810 nm, pulse duration 30 ms, con-
tact cooling, pre-laser [Lux] lotion application. Lumenis
LightSheer. Santa Clara, CA) was used as appropriate for
the LHR treatment. The study protocol was reviewed and
deemed exempt by the Human Subjects Committee of the
Harvard T.H. Chan School of Public Health.
Data collection
UFP count concentrations (particles/cm3) were measured
using TSI Model 3007 Condensation Particle Counters
(CPC) (Shoreview, MN). To measure ambient UFP concen-
trations, a CPC was placed at breathing zone height
(approximately 1.2 m) in the waiting room prior to the
beginning of the first LHR procedure on each day of sam-
pling. The waiting room is connected to the first and
second procedure rooms through a corridor, and is 48.8 m
from the first procedure room and 76.2 m from the second
procedure room. The first and second laser procedure
rooms are separated by other non-laser procedure rooms.
Another CPC was moved between two procedure rooms,
depending on where treatments were occurring. The CPC
was placed on a countertop nearest the procedure table,
approximately 1–2 m away from where the procedure was
being performed. The locations of the instruments in the
procedure rooms were chosen based on the availability of
space and the repeatability of the location. The measure-
ments are likely to underestimate actual occupational expo-
sures due to the distance from the plume source.
The CPCs were programmed to record at 1-s intervals.
For each procedure, the dermatologist documented the
start and stop time of the procedure, the body part under-
going LHR (abdomen, back, bikini, face, legs or underarm),
laser type, fluence, pulse duration, number of laser pulses,
use of pre-laser (Lux) lotion, and whether or not a smoke
evacuator (Buffalo PlumeSafe Turbo) was used during the
procedure. If a smoke evacuator was used, it was held
approximately 30.5 cm away from the treatment area, as
was standard practice at this facility to avoid interfering
with the LHR procedure.
Quality assurance and quality control procedures
All instruments were collocated in the waiting room for
at least 5 min. The CPCs were deemed to have an
acceptable level of precision if the average percent differ-
ence in UFP concentrations between the collocated in-
struments was less than 25%. Pre- and post- sampling
flow rates were measured and recorded for all instru-
ments and a 5% or less deviation from the manufacturer
specified flow rate of 0.7 L/min was deemed acceptable.
Any procedure that did not meet the above quality
control criteria was excluded from the analyses.
Statistical analysis
All statistical analyses were performed using SAS 9.4, SAS
Institute Inc. NC. The 1-s interval data was collapsed into
1-min interval data points for further analysis. Before and
after procedure UFP concentrations were defined as the
average concentrations during the time periods before and
Eshleman et al. Environmental Health  (2017) 16:30 Page 2 of 7
after each procedure, with the time period equal to the cor-
responding procedure duration. For example, if the proced-
ure length was three minutes, the before and after
concentrations would be the average concentrations over
the three minutes prior to the procedure and the three mi-
nutes following the procedure, respectively. Therefore,
three exposure metrics for UFP concentration over time
were available for each procedure.
To account for correlation within the UFP data,
Wilcoxon signed-rank tests were used to assess differ-
ences in the distributions of UFP concentrations between
the waiting room and the procedure rooms overall during
the 4 days of sampling. Longitudinal mixed models with
an unstructured variance-covariance matrix, adjusted for
location (procedure room or waiting room), were used to
analyze differences in the mean concentrations of UFP
over time (before, during, and after the procedures).
To determine predictors of average UFP concentrations
during LHR procedures, univariate Generalized Linear
Regression models were developed. The potential predic-
tors examined included body part (face, bikini, back, legs,
or abdomen), duration of the procedure (in minutes), laser
and pre-laser lotion use (Diode laser with Lux lotion vs.
Alexandrite laser without Lux lotion), and the use of a
smoke evacuator (yes/no). Due to limited sample size,
each covariate, or set of covariates was included in
separate models. A two-sided p-value of 0.05 was used to
determine statistical significance and we examined the
normality of model residuals to determine if the model
using untransformed UFP values were appropriate.
Results
A total of 17 laser hair removal treatments were sampled
over 4 days. The total sample time was 1,087 min in the
procedure rooms and 1,105 min in the waiting room. Four
procedures were excluded for failing the flow rate quality
control checks and an additional procedure was excluded
because the instrument battery died before the procedure
was completed. After these exclusions, 12 procedures
(70.6%) were available for analyses. Procedures ranged
from 1 to 34 min, and included abdomen, face, leg, bikini,
underarm and back treatments (Table 1).
The distributions of UFP concentrations in the waiting
and procedure rooms overall and by time period are
shown in Table 2. The mean UFP concentration in the
waiting room overall (14,957.4 particles/cm3) was lower
than levels in the procedure rooms (22,916.8 particles/
cm3; p < 0.0001). UFP concentration profiles in the wait-
ing and procedure rooms during a typical procedure are
shown in Fig. 1.
UFP concentrations increased rapidly in the procedure
room during a LHR treatment, peaked at the end of the
procedure, and decreased steadily during the after-
procedure period. However, the UFP concentrations did
not return to the pre-treatment concentrations by the
end of the “after treatment” period. There was no no-
ticeable increase in UFP concentrations in the waiting
room during the treatments.
In mixed models, compared to levels before procedures,
the average UFP concentrations in the procedure room
were 2.89 times higher during procedures (p = 0.009) and
2.09 times higher (p = 0.007) after the procedures.
Body part receiving the treatment was a statistically sig-
nificant predictor of UFP exposure (p = 0.013). Body part
predicted 86.7% of the variability in UFP levels. Compared
to LHR procedures on underarms, UFP concentrations
during leg procedures were statistically significantly higher
(Table 3), while all other body parts were lower. Duration
of the procedure was also a statistically significant
predictor of UFP concentration, with each one minute
increase in duration associated with an increase of 3,643.4
particles/cm3 (p = 0.006), after excluding one outlier pro-
cedure (34-min bikini treatment), although overall proced-
ure duration only predicted 58.8% of the variability in UFP
Table 1 Characteristics of all sampled procedures and of sampled procedures included in the final data analysis
All procedures Procedures included in analysis
Duration (min) Duration (min) Average ± Standard Deviation
Ultrafine Particle Concentration
Characteristic N Average Range N Average Range (Particles/cm3)
Body part
Face 4 6 (2–14) 3 6 (2–14) 20,334.32 ± 2,540.94
Bikini 5 12 (4–34) 3 15 (4–34) 41,563.06 ± 16,179.49
Back 2 8 (1–14) 2 8 (1–14) 44,007.44 ± 28,483.18
Legs 2 20 (19–21) 2 20 (19–21) 105,417.27 ± 17,379.98
Underarms 3 5 (2–9) 1 4 – 50,862.5
Abdomen 1 5 – 1 5 – 5,820.04
Lotion used 11 64.71% 6 50.00%
Smoke evacuator used 12 70.59% 8 66.67%
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concentrations. Procedures using the Alexandrite laser
had statistically significantly higher UFP concentrations
(38,614.2 particles/cm3, p = 0.039) compared to proce-
dures using the Diode laser and the Lux lotion. Use of the
smoke evacuator at 30.5 cm away from the skin decreased
concentrations by 14,781.6 particles/cm3 on average, but
this decrease was not statistically significant (p = 0.498)
and described little of the variability in UFP levels (4.6%).
Discussion
In the largest study of occupational exposure to UFP
from LHR to date, we observed statistically significant
elevations in UFP concentrations in procedure rooms
during and after LHR, compared to concentrations be-
fore treatments and concurrent measurements in the
waiting room. A number of procedure characteristics
were associated with higher UFP levels during LHR.
These included the body part undergoing treatment,
laser type and use of Lux lotion, and procedure duration.
Use of a smoke evacuator at 30.5 cm away during the
procedure was not a statistically significant predictor of
UFP concentrations, although there was evidence of
decreased particle counts when in use.
Duration of procedure was the most statistically sig-
nificant predictor of average UFP concentrations and is
a desirable characteristic to consider, as it can be easily
measured in both future studies and in practice. Body
part of the procedure was another statistically significant
predictor of the average concentration of UFP, but pro-
cedures by body part are highly variable by patient, due
to varying density of hair, and are therefore harder to
generalize. The combined use of pre-laser Lux lotion
and the diode laser reduced emissions by up to 60.0%
compared to procedures using the Alexandrite laser.
The pre-laser lotion was used with the contact cooling
diode laser to facilitate cooling and prevent charring. In
contrast, no lotion was used with the Alexandrite laser,
which is equipped with a cryogen Dynamic Cooling
Table 2 UFP concentrations (particles/cm3) in the waiting and procedure rooms overall, and before, during, and after procedures
Location N Mean SD Median IQR 95th percentile 99th percentile
Waiting room
Overall 1105 14,957.4 6,246.8 14,704 3,974–31,700 26,154 29,711
Before LHR 130 14,997.1 4,911.6 15,747 10,492–17,373 24,576 25,060
During LHR 138 15,597.1 5,144.8 16,344 10,787–19,433 23,713 24,712
After LHR 126 16,350.0 4,957.0 16,856 12,112–19,269 24,847 29,189
Procedure room
Overall 1087 22,916.8 24,853.5 15,970 4,882–206,674 72,491 146,442
Before LHR 130 14,332.9 4798.1 15,035 10,170–16,458 24,420 26,211
During LHR 138 55,046.1 47,761.2 37,469 17,671–78,690 158,819 187,185
After LHR 126 36,551.4 24,623.4 27,534 18,876–47,504 87,263 116,617
Fig. 1 Ultrafine particle concentrations (particles/cm3) in a procedure room and waiting room during a typical procedure laser hair removal procedure
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Device (DCD). Two main factors may contribute to
higher UFP count associated with Alexandrite laser hair
removal. First, the shorter pulse duration of the Alexan-
drite laser (3 ms) results in a higher energy delivered
than the diode laser (30 ms), potentially causing in-
creased plume. The Alexandrite was used at a frequency
of 1.5 Hz and the diode was used at a frequency of 1 Hz.
In addition, the cryogen spray incorporated into the
Alexandrite laser produces a sudden airflow which likely
disperses the UFP, whereas contact cooling in diode laser
produces minimal airflow. Moreover, the use of pre-laser
lotion may prevent thermal charring of the surface hair
shaft and trap the UFP produced during LHR.
Surgical smoke is a known occupational hazard con-
taining UFP [3–11, 27]. An estimated 500,000 healthcare
workers are exposed to laser generated surgical smoke
each year [27]. However, there are no regulatory occupa-
tional standards under the Occupational Safety and
Health Administration (OSHA) specifically for surgical
smoke, only guidelines issued by the National Institute
for Occupational Safety and Health (NIOSH) and the
American National Standards Institute (ANSI) (stan-
dards Z136.3-2014 and Z136.1-2007) [3, 28, 29]. NIOSH
recommends the use of local exhaust ventilation in the
form of smoke evacuators with a suction vacuum pump,
hose, inlet nozzle, and a high efficiency particulate air
(HEPA) filter to reduce the UFP concentration. The rec-
ommendations state that the evacuator nozzle should be
placed within 2 in. of the plume in order to effectively
capture the particles [29]. During the sampled proce-
dures, the use of the smoke evacuator did lead to
decreased average UFP concentrations, although not a
statistically significant reduction in particles. However,
to reduce impact to the LHR workflow, the laser practi-
tioners in this clinic commonly kept the smoke evacua-
tor further than the NIOSH recommended 2 in. from
the operating field (on average about 30.5 cm). Thus, the
data collected in this study did not fully evaluate the
effectiveness of a smoke evacuator to reduce LHR partic-
ulates when used as recommended by NIOSH.
We also observed that particle clearance following the
procedure is steady but not immediate. As in the ex-
ample in Fig. 1, it took approximately the same amount
of time after a procedure for the UFP concentrations to
approach the pre-procedure levels as it did to generate
them (i.e. the procedure duration). This finding suggests
that there is potential for UFP exposures to occur after
the LHR procedure is concluded. Laser practitioners or
medical assistants may be present in the room during
this post-procedure period. It is also possible (although
this did not occur during our sampling) that a subse-
quent procedure could begin in the same room before
there was complete clearance, which could lead to
higher peak UFP concentrations. Although we saw a
steady decrease in UFP concentrations post-procedure,
we did not record a complete return to background con-
centrations during any of our sampling periods.
In the only other study of UFP exposures during LHR,
Chuang et al. reported a 8-fold increase in average UFP
concentrations in the procedure room during a treatment
with the use of a smoke evacuator compared baseline level
in the room prior to any procedure [12], which is consistent
with our findings that peak UFP concentrations in the pro-
cedure room were 6.7 times greater than our background,
waiting room concentrations. The median levels in the pro-
cedure room during treatments were comparable to me-
dian levels observed in urban backgrounds in the Boston
metropolitan area, but were approximately half the median
levels observed within 400 m of major roadways [30]. To
date, no threshold has been observed in studies of the ad-
verse health effects of UFP exposures. The UFP levels ob-
served in this study were more than two times higher than
concentrations at which area-level UFP exposure has been
associated with oxidative stress, potentially producing long-
term health hazards [31]. Therefore, although not a focus
of the current study, it is concerning that the current levels
of UFP exposure experienced during LHR procedures may
have adverse health effects.
Our study has several limitations. First, although we did
sample a number of days, we only had a small number of
procedures available to assess. Small sample size prevented
powering multivariable regression that included all potential
Table 3 Results of Univariate Models Examining Predictors of







Abdomen −45,042.5 23,450.8 0.103
Back −6,855.1 20,309.0 0.747
Bikini −9,299.4 19,147.5 0.644
Face −30,528.2 19,147.5 0.162
Legs 54,554.8 20,309.0 0.036
Underarm 0.0 Ref.







Smoke evacuator use 0.046
No evacuator use 14,781.6 21,035.3 0.498
Evacuator Use 0.0 Ref.
Procedure durationa 0.588
1 min increase 3,643.4 1,016.6 0.006
Each predictor, or set or predictors was assessed in separate generalized linear
regression models
aExcluding a 34-min bikini procedure
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predictors of UFP, or the ability to assess interactions be-
tween predictors. Therefore, we are unable to evaluate sets
of factors (other than laser type and lotion use) that may co-
occur in practice. Further investigations are warranted be-
cause of the potential for confounding between covariates
(i.e. duration of procedure and body part) that we were un-
able to assess. It is likely that other factors, such as specific
clinician performing a procedure, or the coarseness of hair
can play a role in the amount of laser plume generated in
each procedure, but this was not accounted for in our study.
We were also limited in our ability to directly assess occupa-
tional exposures, because the CPCs were located outside of
the dermatologists’ breathing zones to prevent impacting
clinical workflow, which differs from Chuang et al., where
the CPCs were placed at the level of the practitioner and the
patient. Additionally, we were not able to fully evaluate the
effectiveness of the recommended use of a smoke evacuator,
since it was standard practice for the laser practitioners that
participated in this study to use the smoke evacuator at ap-
proximately 30.5 cm from the source, which proved to not
provide a significant reduction in UFP concentrations.
Lastly, we are unable to generalize our results to the full
range of locations where LHR is performed, given different
clinical practices across clinics and beauty salons/spas and
potential differences in the distribution of exposure predic-
tors. While our study was aimed at understanding potential
exposures in a typical clinical setting, a randomized study
design would be best suited to isolating the effects of specific
procedural factors on exposures. Finally, our study cannot
inform the relative benefit of various approaches to reduce
exposures, such as proper evacuator use or increases in spot
or general ventilation. However, based on first principles, we
believe that these approaches would achieve some degree of
exposure reduction.
This is the first study that we know of to look at UFP
concentrations across multiple LHR procedures. Since
the number of LHR appointments can differ greatly
from day to day, a 1-day sample could potentially limit a
study’s ability to capture a dermatologist’s average work-
day exposure. Since our sample was a relatively larger
(N = 12) procedure sample size compared to the only
existing study (N = 1), we were able to assess changes in
particle concentrations before, during, and after each
procedure and assess the impact of procedure character-
istics on average UFP concentrations.
Conclusions
The results of this study demonstrate that LHR procedures
have the potential to introduce UFP exposures that are well
above ambient concentrations, and that there are easily
measured key drivers of exposure. Results of our explora-
tory analysis indicate that duration of the procedure is a
strong indicator of UFP concentrations, but other covari-
ates and potential confounders should be considered
further in future studies. Our results suggest that utilizing a
smoke evacuator outside of the recommended range of 2
in. from the source provides minimal protection for laser
practitioners. Laser practitioners should utilize a smoke
evacuator during every procedure and follow the NIOSH
recommended work practices. The significant decrease in
emissions seen with the use of pre-laser lotion warrants
further research to determine if pre-laser lotion can be used
to mitigate UFP exposures or if these findings were a result
of laser type. Potential mitigation strategies would need to
be tested for compliance and efficacy in a variety of proced-
ure room configurations and for a variety of procedures to
ensure wide applicability and effectiveness.
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